Discovery of novel AdipoRon analogues as potent anti-inflammatory agents against nonalcoholic steatohepatitis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Discovery of novel AdipoRon analogues as potent anti-inflammatory agents against nonalcoholic steatohepatitis
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 244, Issue -, Pages 114800
Publisher
Elsevier BV
Online
2022-09-30
DOI
10.1016/j.ejmech.2022.114800
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AdipoRon Attenuates Inflammation and Impairment of Cardiac Function Associated With Cardiopulmonary Bypass–Induced Systemic Inflammatory Response Syndrome
- (2021) Alexander Jenke et al. Journal of the American Heart Association
- Proresolving lipid mediators and liver disease
- (2021) Joan Clària et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Therapeutic effects of AdipoRon on liver inflammation and fibrosis induced by CCl4 in mice
- (2020) Min Sha et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Discovery of Novel Peroxisome Proliferator-Activated Receptor α (PPARα) Agonists by Virtual Screening and Biological Evaluation
- (2020) Liang Dai et al. Journal of Chemical Information and Modeling
- Nonalcoholic Steatohepatitis
- (2020) Adam C. Sheka et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- AdipoRon, an adiponectin receptor agonist, protects contrast-induced nephropathy by suppressing oxidative stress and inflammation via activation of the AMPK pathway
- (2020) Daqian Gu et al. Clinical and Experimental Nephrology
- Emerging targets and potential therapeutic agents in non-alcoholic fatty liver disease treatment
- (2020) Yu Yang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Relevance of SIRT1-NF-κB Axis as Therapeutic Target to Ameliorate Inflammation in Liver Disease
- (2020) Estefanía de Gregorio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Identification and Characterization of a Novel Adiponectin Receptor Agonist AdipoAI and its Anti‐Inflammatory Effects in vitro and in vivo
- (2020) Wei Qiu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Synthesis and anti-inflammatory activity of saponin derivatives of δ-oleanolic acid
- (2020) Liu Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort
- (2020) Tracey G Simon et al. GUT
- Adiponectin receptor agonist AdipoRon relieves endotoxin-induced acute hepatitis in mice
- (2019) Wen-Ze Xiao et al. CHINESE MEDICAL JOURNAL
- Molecular actions of PPARα in lipid metabolism and inflammation
- (2018) Nadia Bougarne et al. ENDOCRINE REVIEWS
- Inflammation and fibrosis
- (2018) Matthias Mack MATRIX BIOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk
- (2016) Jennifer H. Stern et al. Cell Metabolism
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
- (2016) Elena Buzzetti et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity
- (2013) Miki Okada-Iwabu et al. NATURE
- Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
- (2010) Herbert Tilg et al. HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now